New pathways in immune stimulation: targeting OX40

Immune checkpoint blockers (ICB) reinvigorate the immune system by removing the molecular brakes responsible for the scarce activity of immune phenotypes against malignant cells. After having proven their remarkable role as monotherapy, combinations of anti-Programmed cell death 1 (PD-1)/Programmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves Costa Silva, Carolina, Facchinetti, Francesco, Routy, Bertrand, Derosa, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046367/
https://www.ncbi.nlm.nih.gov/pubmed/32392177
http://dx.doi.org/10.1136/esmoopen-2019-000573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046367/
https://www.ncbi.nlm.nih.gov/pubmed/32392177
http://dx.doi.org/10.1136/esmoopen-2019-000573

Ejemplares similares